Vilnius University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Vilnius Lithuania (1579)

Organization Overview

First Clinical Trial
2003
NCT00300794
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Klinikos | Prof. Dr. Med. Laimonas Griskevicius | Vilnius University | Vilnius University Clinic of Anaesthesiology and Intensive Care | Vilnius University, Faculty of Medicine | Vilnius University Hospital | Vilnius University Hospital Santaros Klinikos | Vilnius University Santariskiu Hospital - Vilnius - Lithuania

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiotoxicity (Phase 3)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Conjunctivitis, Allergic (Phase 2)

Hemoglobinuria (Phase 3)

Hemoglobinuria, Paroxysmal (Phase 3)

Leukemia (Phase 2)

Leukemia, B-Cell (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Opioid-Related Disorders (Phase 4)

Poliomyelitis (Phase 4)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 14